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Introduction
The human pancreas secretes liters of enzymes daily to aid in 
food digestion, and bovine mammary glands produce eight 
liters of milk each day, largely for human consumption. To do 
this, secretory organs must adapt to the increased need for pro-
tein secretion that occurs during development, differentiation, 
or changing physiological conditions. An important question 
is how changes in secretory capacity are coordinated to allow 
for efficient targeting, folding, modification, and delivery of se-
creted products. A few transcription factors have been discov-
ered to up-regulate genes in the secretory pathway, including 
Xbp1, which is expressed and required in B cells as they dif-
ferentiate into antibody secreting plasma cells (Shaffer et al., 
2002), and which also regulates secretory function in a subset 
of specialized secretory organs (Shaffer et al., 2004; Lee et al., 
2005). The bZip transcription factor ATF6 activates expres-
sion of chaperone proteins required for efficient protein folding 
(Adachi et al., 2008) as well as many of the lipid components 
of secretory organelles (Bommiasamy et al., 2009). Two other 
bZip  transcription  factors,  Creb3L1/OASIS  and  Creb3L2/
BBF2H7 (herein referred to as Creb3L1 and Creb3L2), are 
required for efficient bone deposition and cartilage matrix   
secretion, respectively (Murakami et al., 2009; Saito et al., 
2009). A major question is whether these transcription factors 
function more broadly to up-regulate the entire secretory path-
way in multiple specialized cell types or if their function is re-
stricted to the up-regulation of only a subset of secretory genes 
in a few specialized cells.
The Drosophila salivary gland (SG) provides an excellent 
model for identifying and studying the factors required for se-
cretory function. The SG is the largest secretory organ in Dro-
sophila, and the processes of morphogenesis and differentiation 
have been well characterized (Kerman et al., 2006). The SG 
comprises two large secretory tubes, each containing 100 po-
larized epithelial cells that are specialized for the production 
and delivery of secreted proteins. Consistent with the high-level 
secretory activity of the SG, at least 34 secretory pathway com-
ponent genes (SPCGs) are highly expressed in the secretory 
cells (Abrams and Andrew, 2005), and this expression requires 
at least two transcription factor genes, fork head (fkh) and CrebA 
(Andrew et al., 1997; Myat et al., 2000).
SG expression of fkh and CrebA is activated in the most 
posterior head segment (parasegment two) by the homeotic gene 
Sex combs reduced (Scr) and two more generally expressed home-
otic cofactor genes extradenticle (exd) and homothorax (hth; 
Henderson and Andrew, 2000). Dpp signaling in dorsal cells blocks 
expression of fkh and CrebA, limiting their activation to only 
the ventral cells of parasegment two (Henderson et al., 1999). 
S
ecretion occurs in all cells, with relatively low levels 
in most cells and extremely high levels in special-
ized secretory cells, such as those of the pancreas, 
salivary, and mammary glands. How secretory capacity 
is selectively up-regulated in specialized secretory cells is 
unknown. Here, we find that the CrebA/Creb3-like family 
of bZip transcription factors functions to up-regulate ex-
pression of both the general protein machinery required 
in all cells for secretion and of cell type–specific secreted 
proteins. Drosophila CrebA directly binds the enhancers 
of secretory pathway genes and is both necessary and 
sufficient to activate expression of every secretory path-
way component gene examined thus far. Microarray pro-
filing reveals that CrebA also up-regulates expression of 
genes encoding cell type–specific secreted components. 
Finally,  we  found  that  the  human  CrebA  orthologues, 
Creb3L1 and Creb3L2, have the ability to up-regulate the 
secretory pathway in nonsecretory cell types.
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Finally,  we  confirmed  Creb3L1  and  Creb3L2  as  the  closest 
mammalian orthologues to Drosophila CrebA and demonstrated 
that both human proteins have the same activities as their Dro-
sophila counterpart.
Results
CrebA binds directly to SPCG enhancers  
in vitro and in vivo
Drosophila  CrebA  expression  is  elevated  in  many  secretory 
organs in the embryo, with highest expression in the develop-
ing SG, proventriculus, late trachea, and epidermis (Fig. 1 A; 
Andrew et al., 1997). In these tissues, CrebA is required for the 
high level expression of 34 known SPCGs (Abrams and Andrew, 
2005). A MEME analysis (http://meme.sdsc.edu/meme/) of the 
enhancer regions upstream of these genes revealed a conserved 
motif similar to the previously characterized CREB response 
element (Montminy and Bilezikjian, 1987) and unfolded protein 
response elements (Wang et al., 2000) that bind the mammalian 
CREB proteins (Fig. 2 A; Abrams and Andrew, 2005). To ask if   
the more distantly related CrebA protein binds these sites in vitro,   
we performed electrophoretic mobility shift assays (EMSAs)   
with 30-nucleotide double-stranded oligomers corresponding 
Shortly after activation of fkh and CrebA, expression of Scr, exd, 
and hth disappears in the SG (Henderson and Andrew, 2000); 
continued expression of both fkh and CrebA is maintained by 
Fkh (Abrams and Andrew, 2005). Thus, we propose that Fkh 
plays a primarily indirect role in SPCG expression through its 
role in maintaining expression of CrebA (Abrams and Andrew, 
2005). Consistent with this idea, the loss of fkh affects only late 
SPCG expression, whereas loss of CrebA affects both early and 
late SPCG expression. It is unknown, however, if CrebA directly 
regulates SPCG expression or if additional downstream factors 
are also involved.
Here, we show that CrebA is both necessary and sufficient 
for high level SPCG expression in the secretory tissues of the 
Drosophila embryo. We show that direct binding of CrebA to a 
consensus motif identified upstream of the 34 originally charac-
terized SPCGs is required for elevated SPCG expression in the 
secretory  tissues. Through  microarray  analysis,  we  find  that 
over half of the 383 genes that require CrebA encode identifi-
able secretory pathway components. Surprisingly, CrebA tar-
gets  include  not  only  components  of  the  general  secretory 
machinery that function in all cells but also cell type–specific 
secreted cargo. Moreover, phenotypes associated with loss of 
CrebA are consistent with the role of this gene in secretion.   
Figure 1.  CrebA is expressed in secretory tissues and regulates SPCG expression. (A) Endogenous CrebA protein is detected in the SGs (asterisks), epider-
mis (arrowheads), and proventriculus (arrows) beginning at stage 11 (lateral view) and continuing through stage 16 of embryonic development (images of 
stage 13, 15, and 16 are ventral views). Elevated expression is also detected in the trachea, but is not visible in these images. (B) Cartoon representation 
of the protein complexes represented by the five enhancers characterized in this study. (C) In situ hybridizations show loss of SG (black asterisks), proven-
triculus (arrows), and epidermal expression (arrowheads) in the CrebA mutant. Bars, 125 µm.481 Transcriptional regulation of secretory capacity • Fox et al.
Figure 2.  CrebA directly activates SPCG expression. (A) The CrebA consensus motif identified upstream of 34 SPCGs by MEME analysis (Abrams and 
Andrew, 2005). (B) EMSAs reveal that CrebA binds to radio-labeled double-stranded oligonucleotides containing the CrebA consensus motif (green 
sequence). Unlabeled wild type (wt) double-stranded oligonucleotides compete for CrebA binding, whereas unlabeled double-stranded oligonucleotides 
containing mutated consensus motifs (red sequence, mut) do not. (C) ChIP analysis using CrebA-specific antibodies, followed by quantitative PCR, revealed 
that SPCG enhancer regions exhibit increased CrebA occupancy when compared with control genes. This figure shows the mean from one representa-
tive trial (out of three). Of note, Spase25-2 showed lower occupancy in one trial, whereas Cop-2 showed higher occupancy in the other two trials. ddCt 
indicates the relative abundance of a gene (or DNA fragment) normalized to a housekeeping gene (actin5c) and normalized to an IgG control. Error bars 
represent standard error of the mean.JCB • VOLUME 191 • NUMBER 3 • 2010   482
Figure 3.  SPCG expression in vivo requires the CrebA consensus motif. (A) The structures of the lacZ reporter gene constructs are represented above 
each gene name, with putative CrebA binding sites represented by orange circles. LacZ reporter lines show high-level SG expression in wild-type embryos 
(top row), which is significantly reduced in CrebA mutants (second row from the top). Mutation of the CrebA response element (CRE) results in significant   
reduction of -gal expression for SrpR, Sec61, p24.1, and Cop but not for Spase25 (bottom) in otherwise wild-type embryos. Three individual trans-
genic lines are shown for each reporter. Asterisks denote SG location in the mutant lines. Bars, 125 µm. (B) Table showing the number of independent 
transgenic lines analyzed for each mutated enhancer and the relative level of lacZ expression compared with the wild-type reporter lines.
to 18 putative CrebA binding sites found within the CrebA-
dependent  enhancers  of  five  representative  SPCGs:  SrpR, 
Sec61, Spase25, p24.1, and Cop (Fig. 1 C). Each gene en-
codes a protein found in a distinct complex functioning at a dif-
ferent step in early secretion (Fig. 1 B). Using purified CrebA 
protein, we observed strong binding in all cases, as revealed 
by the decreased mobility of CrebA–DNA complexes relative 
to unbound DNA (Fig. 2 B and Fig. S1). The binding is spe-
cific: although unlabeled competitor oligomers corresponding 
to the same sequence as the labeled probe competed for CrebA 
binding in 17 of the 18 sites tested, unlabeled competitor oligos   
in which the five core nucleotides of the consensus motif   
were changed did not compete (Fig. 2 B and Fig. S1). We then 
performed chromatin immunoprecipitation (ChIP) followed by 
quantitative RT-PCR to determine if CrebA binds the enhancer 
regions upstream of these SPCGs in vivo. Chromatin was ex-
tracted from 0–24-h embryos and immunoprecipitated with   
either CrebA antiserum or CrebA preimmune serum as a negative 
control. All tested SPCG enhancers were preferentially pulled 
down with the CrebA antibody (Fig. 2 C). These findings indicate 
that CrebA binds to the conserved CrebA consensus site both   
in vitro and in vivo.
CrebA directly activates SPCG expression
To ask if the CrebA binding sites are required for CrebA- 
dependent expression of SPCGs in vivo, we generated multi-
ple independent transgenic lines in which all of the CrebA 
consensus motifs within the SPCG enhancers were mutated. 
Transgenic lines carrying wild-type SPCG enhancers driving 
lacZ had robust -gal expression in the SGs of wild-type em-
bryos,  which  was  significantly  reduced  in  CrebA  mutants 
(Abrams and Andrew, 2005). When stained in parallel with the 
wild-type constructs, most lines carrying mutated CrebA bind-
ing sites for SrpR, p24.1, Sec61, and Cop had significantly 
reduced levels of SG -gal expression when visualized in   
otherwise wild-type embryos (Fig. 3). Surprisingly, most of the 
mutant Spase25 enhancer lines (8/10) had levels of -gal ex-
pression similar to the wild-type Spase25 enhancer. The resid-
ual SG -gal expression observed with the mutated enhancers 
of  SrpR,  p24.1,  Sec61,  and  Cop  and  the  strong  -gal   483 Transcriptional regulation of secretory capacity • Fox et al.
CrebA regulates additional secretory 
pathway genes as well as secreted cargo
To ask if CrebA is a general regulator of SPCGs, we performed 
microarray analyses comparing RNA from wild-type and CrebA 
mutant embryos (Fig. 5 and Table S3). Not only did we observe a 
significant reduction in the expression levels of the majority of the 
SPCGs previously analyzed in CrebA mutant embryos (changes of 
1.5-fold or greater) but we discovered that many additional genes 
encoding proteins known or suspected to function in secretion were 
similarly affected. Gene ontology (GO) clustering was performed 
using DAVID, a program that weighs the enrichment of a specific 
GO term in a given dataset relative to the frequency of that term in 
the entire genome (Dennis et al., 2003; Huang et al., 2009). This 
analysis revealed that in the absence of CrebA, the GO terms asso-
ciated with secretory pathway function (i.e., cotranslational protein 
targeting to the membrane, secretory pathway, and protein trans-
port) are the most highly enriched in the dataset, with enrichment 
of at least threefold compared with the entire Drosophila genome 
(Fig. 5 B and Table S1). Unexpectedly, many genes predicted to 
encode secreted cargo also showed significantly reduced expres-
sion in CrebA mutants, including larval cuticle proteins, mucins, 
and several secreted enzymes. Indeed, more than half of the 40 
genes most affected by loss of CrebA encode known or predicted 
secreted proteins, including mucins and constituents of the larval 
cuticle. These data indicate that CrebA not only up-regulates genes 
encoding the general secretory machinery found in all cells but 
also activates genes encoding cell type–specific secreted pro-
teins. DAVID analysis of the genes up-regulated in CrebA mutants 
did not reveal enrichment for any specific pathway or biological 
function, which suggests that CrebA functions primarily as a tran-
scriptional activator of genes in the secretory pathway.
expression from the mutated enhancer of Spase25 suggest that 
although CrebA directly activates expression of most SPCGs 
through the sites that bind CrebA in vitro, there may also be 
some activation by CrebA-dependent downstream transcrip-
tion factors, or CrebA may also directly activate SPCG ex-
pression through divergent binding sites still contained within 
the enhancer regions of the mutated SPCGs. Taken together, 
these results indicate that CrebA is required for SPCG expres-
sion, and that full expression of most SPCGs is dependent on 
the  CrebA  consensus  binding  motif  identified  through  the 
MEME analysis.
CrebA is sufficient to induce  
SPCG expression
We next asked if CrebA can induce high-level SPCG tran-
scription in cells that normally only express low or undetect-
able levels of these genes. UAS-CrebA (Rose et al., 1997) was 
expressed using either the breathless-Gal4 (trachea, midline, 
and salivary duct) or engrailed-Gal-4 (epidermal stripes) driv-
ers (Shiga et al., 1996; Weiss et al., 2001). In wild-type em-
bryos, CrebA expression is not detected in the midline cells, 
the salivary duct, or in the engrailed domains, and only moder-
ate levels are detected in the trachea (Fig. 4 A). Ectopic ex-
pression of CrebA resulted in elevated levels of expression of 
all five of the SPCGs in all locations (Fig. 4 A). Neither loss 
nor ectopic expression of CrebB, the most closely related Dro-
sophila gene, had any effect on SPCG expression (Fig. 4 B). 
Thus, expression of CrebA alone is sufficient to up-regulate 
SPCG expression in multiple distinct embryonic cell types, 
which suggests a major role for this transcription factor in up-
regulating secretory capacity.
Figure 4.  CrebA is sufficient to induce SPCG expression. (A) UAS-CrebA expression in ectopic domains using either the btl-Gal4 or the en-Gal4 driver 
results in activation of all tested SPCGs. btl-Gal4 drives UAS-CrebA expression and, consequently, SPCG expression in the trachea and central nervous 
system midline (arrowheads) of late stage 11 embryos (ventral views, first and second rows). en-Gal4 drives UAS-CrebA expression and, consequently, 
SPCG expression in epidermal stripes of early stage 11 embryos (lateral views, third and fourth rows). (B) Ectopic expression of UAS-CrebB by the en-Gal4 
driver does not result in SPCG expression in the engrailed domain. Bars, 125 µm.JCB • VOLUME 191 • NUMBER 3 • 2010   484
Figure 5.  CrebA activates additional secretory pathway genes as well as secreted cargo. (A) Volcano plot showing changes in expression level and statisti-
cal significance of CrebA target genes. Transcripts elevated 1.5× or more in CrebA mutants are labeled red. Transcripts reduced 1.5× or more are labeled 
blue or green. Closed circles indicate significance with a P-value ≤ 0.05. Open circles indicate nonstatistically significant changes. (B) Pie charts showing 485 Transcriptional regulation of secretory capacity • Fox et al.
predicted functions of all 383 genes down-regulated in CrebA mutants in the microarray experiments. The 116 secretory pathway genes are further cat-
egorized according to known function and/or localization (blue box). Unknown genes (89) were further subdivided according to predicted localization 
as ascertained by WoLF PSORT analysis. (C) In situ hybridizations validate CrebA regulation of new target genes identified by microarray analysis. Over-
expression of CrebA using the en-Gal4 driver is sufficient to induce ectopic expression of four of the five newly identified target genes. Asterisks represent 
SG position, and arrows point to epidermis expression. Bars, 125 µm.
 
In addition to known secretory pathway genes, we identified 
89 CrebA target genes encoding proteins of unknown function, i.e., 
with no associated GO terms. A WoLF PSORT analysis (http://
wolfpsort.org/) of these proteins revealed that almost half (44) con-
tain a signal sequence and are predicted to be secreted, with an ad-
ditional 14 containing transmembrane domains and predicted to 
localize to the ER or plasma membrane (Fig. 5 B). Thus, it is likely 
that many of these uncharacterized genes encode either novel se-
cretory pathway components or secreted gene products.
Using  in  situ  hybridization,  we  confirmed  that  several 
genes identified as potential CrebA targets in the microarray 
analysis require CrebA for expression in the SG, proventricu-
lus, and/or epidermis (Fig. 5 C). Interestingly, many of them 
have predicted roles in the secretory pathway. Although CG4848 
does not contain GO annotation, it encodes a Vps51/Vps67 do-
main protein closely related to mammalian Cog1, a member of 
the conserved oligomeric Golgi complex required for protein 
glycosylation. Cct1 encodes choline phosphate cytidyltransfer-
ase, an enzyme that functions in the lipid biogenesis pathway. 
CG1969 encodes a glucosamine 6-phosphate N-acetyltransferase, 
a cytoplasmic enzyme involved in the metabolism of glutamate. 
CG5021 and CG14576 encode unknown proteins, but CG5021 
has  significant  hydrophobic  stretches  that  suggest  multiple 
membrane spans, and CG14576 has an N-terminal signal se-
quence indicating that it likely travels through the secretory 
pathway and is secreted. Similar to the previously tested SPCGs, 
expression of CrebA using the en-Gal4 driver was sufficient to 
induce ectopic expression of a majority of these genes; the ex-
ception is CG14576, which we know requires additional cell 
type–specific transcription factors for its expression (see Dis-
cussion). Thus, the microarray screen has revealed many new 
CrebA target genes known or likely to encode components of 
the secretory pathway as well as the specific protein products 
that are processed and delivered via this pathway.
Loss of CrebA leads to defects consistent 
with secretory dysfunction
Despite the critical role of CrebA in up-regulating secretory 
function, CrebA mutants do not display major morphological 
SG defects; the SGs form normally and are only mildly crooked 
at late stages (Andrew et al., 1997). Transmission EM (TEM) of 
CrebA mutant SGs revealed three overt changes: (1) the lumen 
size was significantly smaller than that of wild-type glands and 
was accompanied by reduced amounts of electron-dense luminal   
material (Fig. 6 A); (2) the mitochondria were concentrated to a 
region apical to the nucleus in contrast to wild-type SGs, where 
mitochondria were distributed throughout the cell (Fig. 6 B); and 
(3) the secretory vesicles were much fewer and smaller than those 
of wild-type SGs (Fig. 6, C–E). The TEM analysis also sug-
gested reduced levels of ER, a change that could not be quantified 
from the TEMs. Although most of the SG defects revealed by TEM 
analysis are fully consistent with a role for CrebA as a general 
activator of secretory function, the change in mitochondrial local-
ization was unexpected; whether or not this change is linked to 
CrebA secretory function remains to be determined.
To  ask  if  CrebA  is  provided  maternally  and  functions   
earlier  in  embryogenesis,  we  generated  homozygous  CrebA 
mutant germ-line clones using the FLP-DFS technique (Chou 
and Perrimon, 1996). Consistent with the absence of detectable 
germ-line expression (Smolik et al., 1992; Rose et al., 1997), ma-
ternal loss of CrebA did not exacerbate the CrebA zygotic loss-of-
function phenotypes. Indeed, cuticle preparations of CrebA
mat-zyg-  
animals revealed the same phenotypes as observed with zygotic 
mutants (Fig. 7, A–D). Also, staining with the apical marker 
Crumbs revealed that, as observed with only zygotic loss of CrebA, 
maternal-zygotic loss of CrebA did not result in overt defects in 
early embryos (Fig. 7, E–H). Thus, CrebA is not required for the 
basal levels of secretion that occur in most cell types and instead 
functions to selectively up-regulate secretory capacity in special-
ized secretory cells, both through its effects on genes encoding 
the general machinery and on genes encoding secreted cargo.
CrebA is related to the mammalian 
proteins Creb3L1 and Creb3L2
BLAST analysis of the Drosophila CrebA protein against the 
human genome revealed its two closest orthologues to be Creb3L1 
(Honma et al., 1999; Nikaido et al., 2001) and Creb3L2 (Fig. 8 A; 
Kondo et al., 2007; Saito et al., 2009), which is consistent with 
earlier findings that Creb3L2, originally named BBF2H7, is highly 
related to Drosophila CrebA, originally named BBF-2 (Abel et al., 
1992; Smolik et al., 1992; Storlazzi et al., 2003; Kondo et al., 
2007). Creb3L1 and Creb3L2 share 25% overall similarity with 
CrebA, with 97% similarity (84% identity) and 79% similarity 
(71% identity) within the DNA binding domains of CrebA with 
Creb3L1 and Creb3L2, respectively (Fig. 8 B). Both human pro-
teins also contain C-terminal transmembrane domains and are 
bound to the ER membrane (Omori et al., 2002; Kondo et al., 
2007). During ER stress, Creb3L1 and Creb3L2 undergo regu-
lated intramembrane proteolysis (RIP), wherein their transcription 
factor domains are released into the cytoplasm and subsequently 
translocated to the nucleus to activate transcription (Kondo 
et al., 2005, 2007; Saito et al., 2007). The roles of both Creb3L1 
and Creb3L2 as sensors and mediators in the unfolded protein 
response have been described, and both are expressed in many 
secretory organs (Omori et al., 2002; Kondo et al., 2005, 2007; 
Saito et al., 2007, 2009; Murakami et al., 2009).
Creb3L1 and Creb3L2 activate SPCG 
expression in Drosophila and human cells
To determine if human Creb3L1 and Creb3L2 have the same activ-
ity as CrebA, we generated UAS lines that allow for Gal4 driven 
expression of both the full-length (FL) and truncated (T) forms JCB • VOLUME 191 • NUMBER 3 • 2010   486
Figure 6.  Characterization of CrebA mutant SGs revealed decreases in secretion and changes in organelle positioning. (A) Low-magnification (980×) TEM 
images of stage 15 SGs (top, wild-type; bottom, CrebA mutant) show a reduction in lumen size and content in the CrebA mutant (bottom). Boxes indicate 
region magnified in B, and the dotted line outlines the SG. Bar, 10 µm. (B) Higher-magnification images (2,850×) of individual cells, with arrows indicating 
the position of the mitochondria. Note the clustering of mitochondria in the right panel (CrebA mutant). (C) High-magnification (15,000×) images of the 
apical regions of a single SG cell with arrows pointing to secretory vesicles (left, wild-type; right, CrebA mutant). Bar, 1 µm. (D) Quantification of secretory 487 Transcriptional regulation of secretory capacity • Fox et al.
vesicle number per cell in an individual slice for wild-type and CrebA mutant SGs. (E) Mean area of the secretory vesicles, determined using ImageJ soft-
ware, for an individual slice for wild-type and CrebA mutant SG cells. P-values in D and E were determined using a two-tailed Student’s t test. Error bars 
represent standard deviation.
 
of Creb3L1 and Creb3L2 in Drosophila embryos. The truncated 
forms correspond to the fully processed proteins and should be 
functionally analogous to Drosophila CrebA (Kondo et al., 2005, 
2007). With the en-Gal4 driver, we detected high-level expression 
of both forms of Creb3L1 and Creb3L2 in the epidermal stripes 
corresponding to engrailed expression (Fig. 8 C). Importantly, we 
also detected robust expression of all five of the SPCGs we tested 
in the engrailed domain with expression of the truncated forms 
of both Creb3L1 and Creb3L2, but not with full-length Creb3L1 
and Creb3L2; these findings are fully consistent with the robust 
localization of the truncated proteins to nuclei and of the full-length 
proteins to the ER (Kondo et al., 2005, 2007). We conclude that 
human Creb3L1 and Creb3L2 can activate SPCG transcription in 
a heterologous system, which suggests a general and direct role 
for this family of bZip transcription factors in mediating high-level 
secretory capacity.
To ask if Creb3L1 can also up-regulate SPCG expression 
in human cells, we performed a microarray analysis of HeLa 
cells expressing the truncated form of Creb3L1 and control 
nonexpressing cells. It should be noted that HeLa cells are 
not specialized for secretion; therefore, this experiment would 
determine  if  the  overexpression  of  Creb3L1  alone  can  up-
regulate the secretory pathway in cells that are not dedicated 
to high-level protein secretion. Thus, it was exciting to dis-
cover that the most highly up-regulated genes in Creb3L1 T 
expressing HeLa cells had GO terms including Golgi vesicle 
transport, secretory pathway, and secretion (Tables S2 and S4).   
The up-regulated set of genes exhibited at least threefold en-
richment in the prevalence of these terms as compared with 
the human genome (Table S2). Thus, like its Drosophila or-
thologue, Creb3L1 can activate expression of multiple com-
ponents of the secretory pathway.
Figure 7.  CrebA is not supplied maternally. (A–D) Cuticle preparations of larvae just before hatching from the vitelline membrane reveal that animals miss-
ing both the maternal (mat-) and zygotic (zyg-) contributions of CrebA are similar to animals missing only zygotic function (note the near complete absence 
of ventral denticles in B and C, and the loss of mouthpart pigmentation in the enlarged views in A’–D’). Paternally-supplied zygotic CrebA
+ is sufficient 
for maternal CrebA mutant larvae to finish embryonic development and hatch. (E–H) Staining with the Crumbs antibody reveals no overt morphological 
changes associated with either the maternal, zygotic, or maternal and zygotic loss of CrebA. All embryos are early stage 15. Bars, 125 µm.JCB • VOLUME 191 • NUMBER 3 • 2010   488
Figure 8.  The CrebA human orthologues Creb3L1 and Creb3L2 are sufficient to up-regulate the secretory pathway genes. (A) A rooted phylogenetic tree 
reveals the relationships among members of the CREB/ATF family of transcription factors from Drosophila melanogaster (Dm), Caenorhabditis elegans 
(Ce), and Homo sapiens (Hs). The red box highlights Drosophila CrebA and its closest family members. (B) Sequence alignment of the CrebA family. The 
truncated forms of Creb3L1 and Creb3L2 contain all N-terminal residues up to the site 2 protease cleavage point. (C) Human Creb3L1 and Creb3L2 489 Transcriptional regulation of secretory capacity • Fox et al.
Saito et al., 2007). Recently published phenotypes of the knock-
out mutations in each of the two genes most closely related to 
CrebA, Creb3L1, and Creb3L2 suggest a more physiological role 
for these genes during normal development, with a major defect 
being failure to secrete the extracellular matrix in the cell types 
expressing the highest levels of each gene (Murakami et al., 2009; 
Saito et al., 2009). These data support a model wherein one or 
more of the remaining members of the family may largely com-
pensate for the loss of secretory capacity associated with the loss 
of any one family member. Indeed, our findings that the expres-
sion of only a single Creb3-like family member in HeLa cells, a 
nonsecretory cell type, is sufficient to activate expression of mul-
tiple components of the secretory machinery further supports this 
hypothesis. Among the many secretory genes induced in HeLa 
cells by Creb3L1 are genes encoding multiple components of 
CopII vesicles: Sec16A, Sec23A, Sec24A, Sec24D, Sec31A, and 
Sar1A. The reduced expression of one or more of these genes 
could explain the ER trapping of ECM proteins observed with the 
loss of either Creb3L1 or Creb3L2.
Our microarray analysis of CrebA mutants revealed that 
CrebA up-regulates transcription of secretory cargo, specifically 
expression of multiple components of the insect cuticle, several 
mucin-like proteins (secreted highly-glycosylated proteins rich 
in serine and threonine), and multiple secreted proteins of un-
known function. Although unexpected, this parallels the finding 
that mouse Creb3L1 directly up-regulates the type I collagen gene 
col1a1, a major secreted component of bone ECM (Murakami   
et al., 2009). Our data also suggests that CrebA may function in 
parallel  with  tissue-specific  regulators  to  control  high-level 
expression of organ-specific cargo. An example is CG14756, 
which  encodes  an  SG-specific  secreted  protein  of  unknown 
function. Loss of CrebA results in a 3.2-fold decrease in the 
expression of this gene based on the microarray analysis, but 
unlike the CrebA targets that show more general expression in 
all secretory tissues, expression of CG14756 could not be in-
duced by CrebA in other cell types, which suggests the addi-
tional requirement for tissue-specific transcription factors for its 
activation (Fig. 5). Indeed, expression of CG14756 is absolutely 
dependent on Fkh (Maruyama, R., personal communication,   
and unpublished data), and the region immediately upstream of   
CG14756 contains a good consensus Fkh binding site 150 bp 
upstream of three clustered CrebA consensus binding sites. 
Thus, we propose that the CrebA/Creb3-like family enhances 
secretory capacity by coordinately up-regulating expression of 
the general secretory machinery and of tissue-specific secreted 
cargo, with the expression of cargo genes likely mediated through 
cooperation with tissue-specific factors.
More than 30% (116 of 383) of genes identified in the 
CrebA microarray experiments had GO terms associated with 
Discussion
Here,  we  provide  evidence  that  the  CrebA/Creb3-like  bZIP 
transcription factors are direct and major regulators of secre-
tory capacity. Drosophila CrebA directly activates high-level 
expression of SPCGs through a site we found to be conserved 
among the enhancers of 34 CrebA-dependent SPCGs. More-
over, ectopic expression of CrebA in multiple tissues is suffi-
cient to activate high-level expression of every SPCG tested. 
Microarray analysis indicates that CrebA is required for full 
expression of 400 genes, including almost 200 implicated in 
secretion. The secretory target genes include general machinery 
required for secretion in all cells as well as cell type–specific 
secreted cargo, such as the cuticle proteins and mucins. Pheno-
typic characterization of CrebA mutant SGs revealed a range 
of expected secretory defects, including reduced luminal secre-
tory content and a decrease in the size and frequency of apical 
secretory vesicles, as well as unexpected changes in organelle 
distribution. We demonstrated that active forms of the closest 
vertebrate orthologues Creb3L1 and Creb3L2 activate the Dro-
sophila SPCGs when expressed in embryos. Active Creb3L1 
can also induce expression of multiple components of the se-
cretory pathway when expressed in HeLa cells, a nonsecretory 
cell type.
CrebA is the single Drosophila member of the Creb3-like 
family of transcription factors that includes five different proteins 
in mammals (Creb3/Luman, Creb3L1/Oasis, Creb3L2/BBF2H7,   
Creb3L3/CrebH, and Creb3L4/Creb4) and two in worms (C27D6.4 
and F57B10.1; Fig. 8 A). This singularity means that the fly   
protein is likely to play a more pivotal role in the regulation of   
secretion because there is no possibility of compensation for   
its activity by other family members. Each member of the   
Creb3-like family has a unique expression pattern, with some 
overlap among family members. Creb3/Luman is most highly ex-
pressed in the brain, with expression detected in the liver, intes-
tine, colon, and skeletal muscles (Audas et al., 2008). Creb3L1 is 
expressed in osteoblasts, prostate, pancreas, ovary, testis, the gut, 
lungs, kidney, and SGs (Nikaido et al., 2001; Omori et al., 2002). 
Creb3L2 is expressed in chondrocytes, heart, lung, liver, kidney, 
adrenal gland, bladder, submandibular gland, brain, ovary, pan-
creas, spleen, testis, and prostate (Kondo et al., 2007). Creb3L3/
CrebH is almost exclusively detected in the liver (Chin et al., 
2005),  whereas  Creb3L4/Creb4  expression  is  elevated  in  the 
prostate, thymus, brain, pancreas, skeletal muscle, and peripheral 
leukocytes (Cao et al., 2002). Unlike the Drosophila and worm 
orthologues, all five members of the Creb3-like family are ER-
bound transcription factors previously implicated as sensors in 
the unfolded protein response (UPR; Kondo et al., 2005, 2007; 
Liang et al., 2006; Stirling and O’hare, 2006; Zhang et al., 2006; 
up-regulate SPCGs. The top row shows wild-type expression of each SPCG tested. Overexpression of UAS-Creb3L1 (full-length [FL] or truncated [T]) and 
UAS-Creb3L2 (FL or T) using the en-GAL4 driver resulted in robust mRNA expression in epidermal stripes (first column). Overexpression of the full-length 
forms did not affect SPCG expression, whereas expression of the active truncated forms induced high-level expression of every SPCG tested. Bar, 125 µm. 
(D) HeLa cells transfected with either the FL or T forms of the Creb3L1 or Creb3L2 cDNAs. For both, the full-length protein is detected in the ER, whereas 
the active truncated form is predominantly detected in nuclei. Bar, 20 µm. (E) Microarray analysis of HeLa cells expressing the active truncated form of 
Creb3L1 compared with control HeLa cells reveals a significant increase in the expression of many SPCGs. Genes represented in red (increased) or blue 
(decreased) show a fold change of at least 1.25. Open circles indicate nonsignificant changes.
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roles in the secretory pathway (Fig. 5), and WoLF PSORT pre-
dictions suggested that more than half of the unknown targets 
are likely to have roles in secretion. Indeed, genes not impli-
cated in the secretory pathway may, nonetheless, participate 
in secretion. Several of the ion channel/transporter genes have 
human  orthologues  known  to  function  in  secretory  pathway 
organelles; for example, CG10449 (Drosophila catsup, human 
SLC39A7) encodes a Golgi-localized zinc transporter (Huang 
et al., 2005). Also, 26 of the target genes that did not have GO 
annotations have highly conserved human orthologues, several 
of which are involved in secretion. For example, CG4293 and 
CG7011 encode proteins similar to ERGIC2 and ERGIC3, re-
spectively, which are proteins localized to the ER–Golgi inter-
mediate compartment that function in protein folding and 
trafficking (Nishikawa et al., 2007). Thus, it is likely that many 
of the newly identified CrebA target genes encode proteins that 
function in secretory organelles, highlighting the potential of 
the microarray studies to reveal new genes with key roles in the 
efficient production and delivery of products through the secre-
tory pathway.
Altogether, our studies reveal that CrebA and its human 
orthologues  Creb3L1  and  Creb3L2  activate  transcription  of 
components that function at all steps in secretion. Coordinate 
up-regulation of secretory components by one (or a very few) 
transcription factors allows for easily adjustable levels of secre-
tory capacity in a variety of cell types, as nicely exemplified in 
the Drosophila embryo, where levels of CrebA and correspond-
ing SPCG expression correlate with the levels of secretory activ-
ity in the different tissues. Furthermore, our microarray analysis 
combined with the recent studies of Creb3L1 and Creb3L2 in 
specialized cell types (osteoblasts and chondrocytes; Murakami 
et al., 2009; Saito et al., 2009) suggest that CrebA family proteins 
also up-regulate expression of tissue-specific secreted content, 
highlighting the significance of this protein family in secretory 




wR23 protein null allele was used for all loss-of-function analysis 
(Andrew et al., 1997). UAS-CrebB and CrebB
S162 were obtained from the 
Bloomington Stock Center: HS-FLP and P{ovo
D} FRT2A (79D)/TM3 were 
obtained from E. Chen (Johns Hopkins University School of Medicine, Balti-
more, MD). Recessive lethal lines were balanced over lacZ or GFP balanc-
ers to allow identification of homozygous mutants. UAS-Creb3L1-FL/T and 
UAS-Creb3L2-FL/T were generated by Gateway (Invitrogen)-mediated cloning 
and recombination into the pTW untagged UAS vector (Drosophila Gateway 
Collection, Carnegie Institute). engrailed (en)-Gal4 and breathless (btl)-
Gal4 were used to express UAS-CrebA (Rose et al., 1997), UAS-Creb3L1 
FL, UAS-Creb3L1 T, UAS-Creb3L2 FL, or UAS-Creb3L2 T constructs in epi-
dermal stripes (en-Gal4; Weiss et al., 2001), or the trachea, salivary duct, 
and midline (btl-Gal4; Shiga et al., 1996).
EMSAs
Plus and minus strand oligonucleotides of 30 bases were designed and 
synthesized (IDT DNA) for each binding site, and included the nine-nucleotide 
consensus motif flanked by 10 nucleotides of genomic sequence at both 
the 5 and 3 ends. The plus strand of each oligo was labeled with -
32P 
using the manufacturer’s protocol (Invitrogen) and was annealed to the 
minus strand by heating the DNA to 95°C for 5 min and then cooling to RT. 
Unlabeled double-stranded oligos were prepared similarly for competition ex-
periments. DNA binding reactions were performed as described previously 
(Smolik et al., 1992), with the exception that all competitor oligonucleotides 
were added at concentrations of 20×, 60×, and 100×. Binding reactions 
were run on a 4% polyacrylamide gel at 30 mAmps for 2 h and pre-
pared for autoradiography using standard methods.
Site-directed mutagenesis of SPCG enhancer-lacZ reporters
Primers for putative CrebA binding sites (Abrams and Andrew, 2005) were 
designed to mutate the five core nucleotides of the CrebA-binding motif 
G/TACGT to ACAAC using the Stratagene Primer Design program (Agi-
lent Technologies). Sites were subsequently mutated using the QuikChange 
Multi Site-Directed Mutagenesis kit (Agilent Technologies), and the mutated 
constructs were injected into w
1118 flies (Rainbow Transgenic Flies Inc.).
ChIP and quantitative PCR
The ChIP followed the protocol of Birch-Machin et al. (2005). Quantitative 
real-time PCR was performed using 1 µl of eluted sample DNA, 1.5 µM for-
ward and reverse primers, and iQ SYBR Green Supermix (Bio-Rad Laborato-
ries). Experiments were performed in triplicate, including those from an input 
control. Samples were normalized to actin5c, and fold change over the no-
primary antibody control was calculated using the ddCt method (Livak and 
Schmittgen, 2001). Error bars represent the standard deviation of ddCt.
TEM
CrebA mutant embryos were identified by the absence of GFP staining 
from the TM3 balancer chromosomes. Stage 16 wild-type and CrebA mutant 
embryos were processed for TEM using standard protocols and examined 
on a microscope (EM120; Philips). To determine secretory vesicle size, 
area measurements were collected using ImageJ software (National Insti-
tutes of Health), and statistical significance was determined using a two-
tailed Student’s t test.
Immunohistochemistry and in situ hybridizations
In situ hybridization and immunohistochemistry were performed as previ-
ously described (Reuter et al., 1990; Lehmann and Tautz, 1994). Antibody 
concentrations used in this study were as follows: -CrebA (1:1,000; 
Andrew et al., 1997), -Crumbs (1:100; Developmental Studies Hybridoma 
Bank), and --galactosidase (1:10,000; Promega). All secondary anti-
bodies (Vector Laboratories and Invitrogen) were used at a 1:500 dilution. 
The fluorochrome Alexa Fluor 568 was used for HeLa cell experiments, 
and nuclei were labeled with DAPI. Confocal images were obtained using 
a confocal microscope (LSM 510 Meta; Carl Zeiss, Inc.), using a Plan-
Neofluor 40×, 1.3 NA oil objective and the LSM software (Carl Zeiss, 
Inc.). All other images were obtained using an microscope (Axiophot; Carl 
Zeiss, Inc.) configured with a digital camera (Coolpix 4500; Nikon). Images 
were taken using a Plan-Neofluor 20×, 0.50 NA objective. Images were 
rotated and cropped using Photoshop (Adobe). All images were obtained 
at room temperature.
Generation of CrebA maternal-zygotic mutants
CrebA
23w- was recombined onto a third chromosome containing FRT2A 
(79D) and then crossed to flies carrying hsFLP; P{ovo
D} FRT2A (79D). After 
72 h, larvae were heat-shocked for 1 h at 37°C on consecutive days until   
pupae formation. Female flies carrying both CrebA
23w- FRT2A(79D) and 
P{ovo
D} FRT2A (79D) were crossed to CrebA
23w-/TM6B, Ubx-lacZ males, 
and progeny were collected and stained using the appropriate markers. 
CrebA
mat-zyg- embryos were identified based on the absence of staining for 
-gal from the lacZ-containing balancer.
Microarray experiments to identify CrebA target genes in Drosophila
Three samples of sorted stage 11–16 CrebA homozygous (GFP balancer 
negative) mutant embryos and wild-type OR embryos were isolated using 
a COPAS Select embryo sorter (Union Biometrica). Total RNA was isolated 
using TriZOL chloroform extraction and precipitated with isopropanol. The 
RNeasy kit (QIAGEN) was used for RNA clean up. Total RNA (100 ng) 
was labeled according to standard Affymetrix protocols and hybridized 
to the Drosophila genome 2.0 chip. After scanning, intensity values were 
normalized by RMA (Partek Inc.; Irizarry et al., 2003a,b), and statisti-
cal analysis was performed using Spotfire software (TIBCO). CrebA target 
genes were identified based on a 1.5-fold change in gene expression, with 
a p-value ≤ 0.05. This fold change was selected because many known, 
confirmed, CrebA target genes fall into the range of 1.5–2.0×.
HeLa cell culture, transfection, and immunofluorescence
cDNAs corresponding to the full-length Creb3L1 and Creb3L2 were ob-
tained  from  Thermo  Fisher  Scientific  (accession  nos.  BC015781  and 
BC110813, respectively, from the Mammalian Gene Collection), and the 491 Transcriptional regulation of secretory capacity • Fox et al.
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